Quality of life in oncology clinical trials: Present and future challenges

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 2, Issue 2, 2002, Pages 84-86

  Bottomley, Andrew ^a   Flechtner, Henning ^a  

^a EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; BREAST CANCER; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL TRIAL; DATA ANALYSIS; DRUG INDUSTRY; DRUG LABELING; FATIGUE; FOOD AND DRUG ADMINISTRATION; HUMAN; INFORMATION PROCESSING; LIBIDO; MEDICAL SOCIETY; NOTE; ONCOLOGY; OUTCOMES RESEARCH; PATIENT CARE; PSYCHOMETRY; QUALITY CONTROL; SCORING SYSTEM; SEXUAL FUNCTION; THEORY;

EID: 0036076066     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.2.2.84     Document Type: Note

References (2)

1. A review of health-related quality of life in advanced breast cancer patients undergoing systemic therapy
2. Interpreting the significance of changes in health-related quality of life scores